1. Carter, C. H., Maley, M. C.: Clinical evaluation of Peganone®, a new anticonvulsant. Amer. J. Med. Sci. 234, 74 (1957).
2. Chang, T., Glazko, A. J.: Quantitative assay of 5,5-diphenylhydantoin (Dilantin®) and 5-(p
- hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography. J. Lab. clin. Med. 75, 145 (1970).
3. Dudley, K. H., Bius, D. L., Butler, T. C.: Metabolic fates of 3-ethyl-5-phenylhydantoin (ethotoin, Peganone®), 3-methyl-5-phenylhydantoin and 5-phenylhydantoin. J. Pharmacol, exp. ther. 175, 27 (1970).
4. Gruber, C. M., jr., Brock, J. T., Dyken, M.: Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures. Clin. Pharmacol. Ther. 3, 23 (1962).
5. Hammer, R. H., Wilder, B. J., Streiff, R. R., Mayersdorf, A.: Flash methylation and gasliquid chromatography of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin. J. pharm. Sci. 60, 327 (1971).